An epidemiological study of head trauma patients receiving antithrombotic drugs

An epidemiological study of head trauma patients receiving antithrombotic drugs - An epidemiological study of head trauma patients receiving antithrombotic drugs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037283

Enrollment

1500

Registered

2019-10-01

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects of this study will consist of patients with head trauma, aged over 65 years, requiring admission.

Exclusion criteria

Exclusion criteria: (1) Chronic subdural hematoma (2) Patients with cardiopulmonary arrest on arrival

Design outcomes

Primary

Measure	Time frame
A national survey regarding age/sex/injury mechanism/diagnosis/compliance with antithrombotic drugs/neutralization of these drugs/outcomes involving patients with head trauma will be conducted. Furthermore, whether the contents of treatment influence the outcome will be investigated.In registered patients with head trauma, the status/treatment during the admission period will be examined. Approximately 90 items will be observed. The outcome will be assessed on discharge and 6 months after injury. The observation period is 6 months after injury at maximum.	—

Measure

Time frame

A national survey regarding age/sex/injury mechanism/diagnosis/compliance with antithrombotic drugs/neutralization of these drugs/outcomes involving patients with head trauma will be conducted. Furthermore, whether the contents of treatment influence the outcome will be investigated.In registered patients with head trauma, the status/treatment during the admission period will be examined. Approximately 90 items will be observed. The outcome will be assessed on discharge and 6 months after injury. The observation period is 6 months after injury at maximum.

—

Countries

Japan

Contacts

Public ContactEiichi Suehiro

International University of Health and Welfare, School of Medicine Neurosurgery

suehiro-nsu@umin.ac.jp0476-35-5600

Outcome results